- •Most reported "side effects" are dose-curve issues, not toxicity. The first move on most symptoms is schedule frequency or titration speed, not stopping the protocol.
- •Three categories matter: transient (resolves in 1-4 weeks at steady state), protocol-adjustable (responds to dose/schedule/compound change), hard stop (workup before another dose).
- •Daily symptom logging is the highest-leverage tool. Most patterns, Friday slump on weekly TRT, GLP-1 nausea peaking on dose day, GH headache on first week, are visible in 2-3 weeks of daily logs.
- •Cross-protocol users compound side effects. TRT + GLP-1 + peptides interact; logging in one place beats logging in three.
Overview
Side effects on these protocols sort cleanly into three buckets: things that resolve at steady state, things that respond to a protocol adjustment, and things that mean stop and work up. The hard part is telling them apart in real time, which is why daily symptom logging is the single highest-leverage tool a user can run.
This page collects the side-effect deep-dives across all three pillars. Start here:
The patterns daily logs surface that clinic visits don't
The patterns that show up in daily logs but not in clinic visits:
- Weekly TRT "great Monday, dragging Friday." Almost always solved by splitting to twice-weekly without changing total dose. The peak-trough swing on a once-weekly schedule is the cause.
- GLP-1 nausea peaking 24–48h after dose, fading by day 4–5. Expected and self-resolving for most users; the action threshold is dehydration risk or persistence past dose 3.
- GH-class peptide headache and water retention in week 1. Expected; resolves at steady state.
- TRT mood spike or anxiety on dose day. Schedule problem, not testosterone problem. Move to smaller, more frequent doses before reaching for an aromatase inhibitor.
- GLP-1 muscle loss without a body composition change in the mirror. Visible only in weight-trend + body-fat trend together, not in scale weight alone.
- Peptide site reactions clustering in one anatomical area. Rotation problem, not compound problem. Spread across more sites and most reactions clear.
All of these are pattern-match problems, not diagnostic problems. The fastest way to see them is daily logging tied to dose timing.
Deep-dive index
The articles below are the deep-dives that informed this hub, grouped by primary pillar. Each one expands on a specific question from the sections above.
From the TRT pillar
- Trt Mental Health Depression Anxiety
- Trt Side Effects Management Guide
From the GLP-1 pillar
- GLP-1 Hair Loss: The Shedding Timeline and What Actually Helps, Hair shedding on Ozempic, Wegovy, Mounjaro, or Zepbound is telogen effluvium triggered by rapid weight loss. Timeline, risk factors, and what works.
- Glp1 Muscle Loss Guide
- Glp1 Muscle Loss Trt Prevention
- GLP-1 Plateau: Why You Stopped Losing Weight, How to tell a real GLP-1 plateau from a fake stall, the 7 most common causes, when to increase your dose vs wait, and tracking strategies.
- Glp1 Side Effects Digestive Fix
- Sulfur Burps on Ozempic, Wegovy & Mounjaro, GLP-1 sulfur burps caused by delayed gastric emptying. Timeline, trigger foods, what works (ginger, smaller meals, split dosing) and what doesn't.
- Glp1 Weight Regain Guide
- Retatrutide Side Effects Guide, Week-by-week timeline of retatrutide side effects at each dose tier (2mg through 12mg), including unique glucagon receptor effects, management strategies, when to lower dose, and comparison to tirzepatide and semaglutide side effects.
In the OptiPin app
OptiPin's daily check-in captures mood, sleep quality, libido, energy, and free-text symptom notes against your dose timeline. The AI summary reads daily logs alongside dose history, weight, body composition, and lab markers, then surfaces correlations as a weekly digest and a month-in-review summary, Friday slumps, dose-day mood spikes, and GLP-1 nausea windows show up as patterns within 2-3 weeks. For protocol-adjustable side effects, that's typically the difference between a protocol you change once and a protocol you tinker with for six months.
Frequently Asked Questions
When does a side effect become a reason to stop the protocol?
Specific signals: confirmed cardiac arrhythmia (TRT), pancreatitis or persistent severe vomiting (GLP-1), persistent visual changes or severe headache (any GH-class peptide), uncontrolled hypertension on minoxidil, signs of post-finasteride syndrome on 5-AR inhibitors. Almost everything else is a protocol-adjust, not a stop.
Should I treat "high estradiol" symptoms with an AI?
Almost never as the first move. Crashed estradiol from over-aggressive AI dosing is worse than slightly elevated estradiol with no symptoms. The first move for most TRT estradiol issues is more frequent, smaller doses (lower peaks → less aromatization). Reserve aromatase inhibitors for confirmed symptomatic high estradiol that doesn't respond to schedule changes.
How do I tell GLP-1 muscle loss from normal weight loss?
Track lean mass proxies, DEXA scans (every 3 months on cycle), grip strength, training output (weights moved, reps achieved), alongside scale weight. Scale weight alone tells you nothing about composition. The OptiPin app pulls Apple Health body-fat estimates from compatible scales and overlays them on the weight trend, so the lean-mass-loss signature is visible without manual reconciliation.
Track Your Protocol in OptiPin
Log doses, forecast hormone and compound levels, rotate sites, daily symptom check-ins, and lab tracking, all private and on-device.
Download on the App Store